LongeVC: A venture firm propelling early-stage biotech startups towards growth and capital raise.
Location
Lugano, Ticino, CH
Founded
2020
LongeVC is an international venture capital firm dedicated to investing in early-stage biotechnology startups with a focus on longevity and health transformation. The firm aims to support exceptional founders in bringing breakthrough biotech innovations to market. LongeVC typically engages in Series A funding rounds, helping companies gain industrial momentum and secure necessary capital for growth.
Notable portfolio companies include AOA Dx, SiPhox Health, and Unnatural Products, which have collectively raised significant capital. The firm is led by a team of experienced partners who provide not only financial backing but also strategic guidance and access to a global network of industry experts. LongeVC's investment philosophy centers on fostering an ecosystem of biotech and longevity-focused companies that have the potential to change the world.
LongeVC - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series A3 (75.0%)
Series B1 (25.0%)
Stage Mix
Series A 75%Series B 25%
Concentration shown as share of disclosed investments by stage.